{"id":342475,"date":"2026-11-07T16:26:12","date_gmt":"2026-11-07T10:56:12","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/divi-s-laboratories-q2-results-fy27-pat-1140-crore\/"},"modified":"2026-11-07T16:26:12","modified_gmt":"2026-11-07T10:56:12","slug":"divi-s-laboratories-q2-results-fy27-pat-1140-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/divi-s-laboratories-q2-results-fy27-pat-1140-crore\/","title":{"rendered":"Divi&#8217;s Laboratories Q2 Results FY27: PAT Rises 65.46% to Rs 1,140 Cr, Revenue Rs 3,647 Cr"},"content":{"rendered":"<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Divi&#8217;s Laboratories Q2 Results FY27 were declared on 7 November 2026, with revenue of Rs 3,647 Cr against Rs 2,715 Cr a year earlier, which is YoY growth of 34.33%. Net profit rose 65.46% to Rs 1,140 Cr from Rs 689 Cr in the same quarter last year. These quarterly results cover July to September 2026.<\/p>\n<\/div>\n<p><a href=\"https:\/\/univest.in\/stocks\/divislab\/divi's-laboratories-ltd-share-price-today\">Divi&#8217;s Laboratories Ltd<\/a> (DIVISLAB) Q2 Results FY27 announced on 7 November 2026, covering the company&#8217;s financial performance for the July to September quarter. The results date brought revenue of Rs 3,647 Cr and net profit (PAT) of Rs 1,140 Cr. Divi&#8217;s Laboratories Q2 Results FY27 are compared with the same quarter a year earlier.<\/p>\n<p>Divi&#8217;s Laboratories Q2 Results are covered here through a results analysis of the financial highlights, business drivers, outlook and risks. Univest has set this quarter against the same quarter of last year, and the Financial Highlights table that follows carries those figures side by side.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=quarterly_results\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/divi-s-laboratories-q2-results-fy27-pat-1140-crore\/#Divis_Laboratories_Q2_Results_FY27_Financial_Highlights\" title=\"Divi&#8217;s Laboratories Q2 Results FY27: Financial Highlights\">Divi&#8217;s Laboratories Q2 Results FY27: Financial Highlights<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/divi-s-laboratories-q2-results-fy27-pat-1140-crore\/#Key_Takeaways_from_Divis_Laboratories_Q2_Results_What_Stands_Out\" title=\"Key Takeaways from Divi&#8217;s Laboratories Q2 Results: What Stands Out\">Key Takeaways from Divi&#8217;s Laboratories Q2 Results: What Stands Out<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/divi-s-laboratories-q2-results-fy27-pat-1140-crore\/#Divis_Laboratories_Q2_Results_FY27_Performance_Analysis\" title=\"Divi&#8217;s Laboratories Q2 Results FY27: Performance Analysis\">Divi&#8217;s Laboratories Q2 Results FY27: Performance Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/divi-s-laboratories-q2-results-fy27-pat-1140-crore\/#Key_Business_Factors_This_Quarter\" title=\"Key Business Factors This Quarter\">Key Business Factors This Quarter<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/divi-s-laboratories-q2-results-fy27-pat-1140-crore\/#FY27_Outlook_After_Divis_Laboratories_Q2_Results\" title=\"FY27 Outlook After Divi&#8217;s Laboratories Q2 Results\">FY27 Outlook After Divi&#8217;s Laboratories Q2 Results<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/divi-s-laboratories-q2-results-fy27-pat-1140-crore\/#Key_Risks_to_Watch_After_Divis_Laboratories_Q2_Results_FY27\" title=\"Key Risks to Watch After Divi&#8217;s Laboratories Q2 Results FY27\">Key Risks to Watch After Divi&#8217;s Laboratories Q2 Results FY27<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/divi-s-laboratories-q2-results-fy27-pat-1140-crore\/#Single_Quarter_Reading\" title=\"Single Quarter Reading\">Single Quarter Reading<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/divi-s-laboratories-q2-results-fy27-pat-1140-crore\/#Return_Reference_Is_Annual\" title=\"Return Reference Is Annual\">Return Reference Is Annual<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/divi-s-laboratories-q2-results-fy27-pat-1140-crore\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/divi-s-laboratories-q2-results-fy27-pat-1140-crore\/#Frequently_Asked_Questions_on_Divis_Laboratories_Q2_Results_FY27\" title=\"Frequently Asked Questions on Divi&#8217;s Laboratories Q2 Results FY27\">Frequently Asked Questions on Divi&#8217;s Laboratories Q2 Results FY27<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/divi-s-laboratories-q2-results-fy27-pat-1140-crore\/#What_are_Divis_Laboratories_Q2_Results_FY27\" title=\"What are Divi&#8217;s Laboratories Q2 Results FY27?\">What are Divi&#8217;s Laboratories Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/divi-s-laboratories-q2-results-fy27-pat-1140-crore\/#What_is_the_results_date_for_Divis_Laboratories_Q2_Results_FY27\" title=\"What is the results date for Divi&#8217;s Laboratories Q2 Results FY27?\">What is the results date for Divi&#8217;s Laboratories Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/divi-s-laboratories-q2-results-fy27-pat-1140-crore\/#What_revenue_was_reported_in_Divis_Laboratories_Q2_Results_FY27\" title=\"What revenue was reported in Divi&#8217;s Laboratories Q2 Results FY27?\">What revenue was reported in Divi&#8217;s Laboratories Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/divi-s-laboratories-q2-results-fy27-pat-1140-crore\/#What_net_profit_was_reported_in_Divis_Laboratories_Q2_Results_FY27\" title=\"What net profit was reported in Divi&#8217;s Laboratories Q2 Results FY27?\">What net profit was reported in Divi&#8217;s Laboratories Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/divi-s-laboratories-q2-results-fy27-pat-1140-crore\/#How_much_YoY_growth_did_revenue_show_in_Divis_Laboratories_Q2_Results_FY27\" title=\"How much YoY growth did revenue show in Divi&#8217;s Laboratories Q2 Results FY27?\">How much YoY growth did revenue show in Divi&#8217;s Laboratories Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/divi-s-laboratories-q2-results-fy27-pat-1140-crore\/#Did_net_profit_rise_or_fall_in_Divis_Laboratories_Q2_Results\" title=\"Did net profit rise or fall in Divi&#8217;s Laboratories Q2 Results?\">Did net profit rise or fall in Divi&#8217;s Laboratories Q2 Results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/divi-s-laboratories-q2-results-fy27-pat-1140-crore\/#What_was_the_net_profit_margin_in_Divis_Laboratories_Q2_Results_FY27\" title=\"What was the net profit margin in Divi&#8217;s Laboratories Q2 Results FY27?\">What was the net profit margin in Divi&#8217;s Laboratories Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/divi-s-laboratories-q2-results-fy27-pat-1140-crore\/#What_was_the_return_on_equity_around_Divis_Laboratories_Q2_Results_FY27\" title=\"What was the return on equity around Divi&#8217;s Laboratories Q2 Results FY27?\">What was the return on equity around Divi&#8217;s Laboratories Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/divi-s-laboratories-q2-results-fy27-pat-1140-crore\/#What_business_factors_shaped_Divis_Laboratories_Q2_Results_FY27\" title=\"What business factors shaped Divi&#8217;s Laboratories Q2 Results FY27?\">What business factors shaped Divi&#8217;s Laboratories Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/divi-s-laboratories-q2-results-fy27-pat-1140-crore\/#What_are_the_key_risks_after_Divis_Laboratories_Q2_Results_FY27\" title=\"What are the key risks after Divi&#8217;s Laboratories Q2 Results FY27?\">What are the key risks after Divi&#8217;s Laboratories Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/divi-s-laboratories-q2-results-fy27-pat-1140-crore\/#What_is_the_outlook_after_Divis_Laboratories_Q2_Results\" title=\"What is the outlook after Divi&#8217;s Laboratories Q2 Results?\">What is the outlook after Divi&#8217;s Laboratories Q2 Results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/divi-s-laboratories-q2-results-fy27-pat-1140-crore\/#Where_can_I_find_the_complete_Divis_Laboratories_Q2_Results_FY27_data\" title=\"Where can I find the complete Divi&#8217;s Laboratories Q2 Results FY27 data?\">Where can I find the complete Divi&#8217;s Laboratories Q2 Results FY27 data?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Divis_Laboratories_Q2_Results_FY27_Financial_Highlights\"><\/span><strong>Divi&#8217;s Laboratories Q2 Results FY27: Financial Highlights<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<tbody>\n<tr>\n<th>Metric<\/th>\n<th>Q2 FY27 (Sep 26)<\/th>\n<th>Q2 FY26 (Sep 25)<\/th>\n<th>YoY Change<\/th>\n<\/tr>\n<tr>\n<td><strong>Revenue<\/strong><\/td>\n<td>Rs 3647 Cr<\/td>\n<td>Rs 2715 Cr<\/td>\n<td>+34.33% YoY<\/td>\n<\/tr>\n<tr>\n<td><strong>Net Profit (PAT)<\/strong><\/td>\n<td>Rs 1140 Cr<\/td>\n<td>Rs 689 Cr<\/td>\n<td>+65.46% YoY<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Source: company filing for Divi&#8217;s Laboratories Q2 Results FY27, 7 November 2026. Figures in Rs Crore.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Takeaways_from_Divis_Laboratories_Q2_Results_What_Stands_Out\"><\/span><strong>Key Takeaways from Divi&#8217;s Laboratories Q2 Results: What Stands Out<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Revenue Rs 3,647 Cr:<\/strong> up from Rs 2,715 Cr a year earlier, which is YoY growth of 34.33% in the July to September 2026 quarter.<\/li>\n<li><strong>Net profit Rs 1,140 Cr:<\/strong> compared with Rs 689 Cr in the same quarter last year, a rise of 65.46%.<\/li>\n<li><strong>Net profit margin 31.3%:<\/strong> up from 25.4% in the comparison quarter, because net profit grew faster than revenue.<\/li>\n<li><strong>Divi&#8217;s Laboratories Q2 Results FY27:<\/strong> declared on 7 November 2026, with return on equity of 16.19% in FY26.<\/li>\n<li><strong>Risk headline:<\/strong> a single quarter does not set a trend, and the performance analysis below shows where this quarter sits.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Divis_Laboratories_Q2_Results_FY27_Performance_Analysis\"><\/span><strong>Divi&#8217;s Laboratories Q2 Results FY27: Performance Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Divi&#8217;s Laboratories Q2 Results FY27 show revenue rising 34.33% YoY to Rs 3,647 Cr, while net profit rose 65.46% to Rs 1,140 Cr. Net profit therefore grew at almost twice the pace of revenue in this quarter.<\/p>\n<p>In Divi&#8217;s Laboratories Q2 Results, the quarterly results add Rs 932 Cr of revenue over the Rs 2,715 Cr reported a year earlier, and net profit is Rs 451 Cr higher than Rs 689 Cr. This results analysis uses simple differences, so every figure traces back to the supplied numbers.<\/p>\n<p>Investors following Divi&#8217;s Laboratories Q2 Results FY27 will watch whether YoY growth in revenue and net profit carries into later disclosures, since a single quarter does not set a trend. Margin and returns sit behind the figures, which is where the results analysis turns to the business factors.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live results data<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Business_Factors_This_Quarter\"><\/span><strong>Key Business Factors This Quarter<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Revenue Growth<\/strong> &#8211; The results analysis points to three business factors, and the first is revenue, which grew 34.3% year on year to Rs 3,647 Cr in the latest quarter. That expansion forms the base on which the rest of the quarterly results are built.<\/p>\n<p><strong>Net Profit Growth<\/strong> &#8211; Net profit rose 65.5% year on year to Rs 1,140 Cr, the second business factor in Divi&#8217;s Laboratories Q2 Results FY27, which means profit grew faster than revenue over the year-ago quarter.<\/p>\n<p><strong>Net Profit Margin And Return on Equity<\/strong> &#8211; Net profit margin improved to 31.3% from 25.4% in the comparison quarter, and return on equity was 16.19% in FY26. Together these form the third factor, a margin figure for the quarter and a full-year return figure beside it.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"FY27_Outlook_After_Divis_Laboratories_Q2_Results\"><\/span><strong>FY27 Outlook After Divi&#8217;s Laboratories Q2 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>FY27 full-year results will depend on subsequent quarters and on disclosed sector conditions. The net profit of Rs 1,140 Cr in this quarter is one data point, and Divi&#8217;s Laboratories Q2 Results FY27 should be read as part of a longer sequence of filings through the year.<\/p>\n<p>A fuller results analysis becomes possible as later quarters are declared, because each filing adds a new comparison. Investors can use the Univest Screener to follow those filings and track net profit over time, and the risks that follow are the next item to weigh.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_Watch_After_Divis_Laboratories_Q2_Results_FY27\"><\/span><strong>Key Risks to Watch After Divi&#8217;s Laboratories Q2 Results FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Single_Quarter_Reading\"><\/span><strong>Single Quarter Reading<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Divi&#8217;s Laboratories Q2 Results FY27 describe one quarter. A single quarter of YoY growth does not set a trend, so later filings will show whether Rs 1,140 Cr of net profit repeats.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Return_Reference_Is_Annual\"><\/span><strong>Return Reference Is Annual<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Return on equity of 16.19% is an FY26 full-year figure, so it does not measure the July to September 2026 quarter. Investors can compare it with later annual figures when new balance sheets are published.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track quarterly results as they are declared.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Divi&#8217;s Laboratories Q2 Results FY27 show revenue of Rs 3,647 Cr and net profit of Rs 1,140 Cr, both higher than a year earlier. These quarterly results are best read with the FY26 return figure listed above and can be tracked on the Univest app. In short, Divi&#8217;s Laboratories Q2 Results carry no advice, so investors should consult a SEBI-registered advisor before acting.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Divis_Laboratories_Q2_Results_FY27\"><\/span><strong>Frequently Asked Questions on Divi&#8217;s Laboratories Q2 Results FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_are_Divis_Laboratories_Q2_Results_FY27\"><\/span><strong>What are Divi&#8217;s Laboratories Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Divi&#8217;s Laboratories Q2 Results FY27 are the quarterly results for July to September 2026, showing revenue of Rs 3,647 Cr. Alongside this, net profit came in at Rs 1,140 Cr, as set out in the Quick Answer.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_results_date_for_Divis_Laboratories_Q2_Results_FY27\"><\/span><strong>What is the results date for Divi&#8217;s Laboratories Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Divi&#8217;s Laboratories declared its Q2 FY27 results on 7 November 2026, which is the results date for the July to September quarter. This date is also stated in the opening paragraph of this article.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_revenue_was_reported_in_Divis_Laboratories_Q2_Results_FY27\"><\/span><strong>What revenue was reported in Divi&#8217;s Laboratories Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Divi&#8217;s Laboratories reported revenue of Rs 3,647 Cr for Q2 FY27, compared with Rs 2,715 Cr a year earlier, as shown in the Financial Highlights table that follows the introduction.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_net_profit_was_reported_in_Divis_Laboratories_Q2_Results_FY27\"><\/span><strong>What net profit was reported in Divi&#8217;s Laboratories Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Divi&#8217;s Laboratories reported net profit of Rs 1,140 Cr in Q2 FY27, compared with Rs 689 Cr in the same quarter last year, as the Key Takeaways section lists it with its 65.46% rise.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_YoY_growth_did_revenue_show_in_Divis_Laboratories_Q2_Results_FY27\"><\/span><strong>How much YoY growth did revenue show in Divi&#8217;s Laboratories Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue showed YoY growth of 34.33% in Divi&#8217;s Laboratories Q2 Results FY27, moving from Rs 2,715 Cr to Rs 3,647 Cr, which the Performance Analysis section describes as a difference of Rs 932 Cr.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Did_net_profit_rise_or_fall_in_Divis_Laboratories_Q2_Results\"><\/span><strong>Did net profit rise or fall in Divi&#8217;s Laboratories Q2 Results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Net profit rose in Divi&#8217;s Laboratories Q2 Results, by 65.46% YoY to Rs 1,140 Cr, while the net profit margin moved to 31.3% from 25.4%, a point covered in the Key Business Factors section.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_the_net_profit_margin_in_Divis_Laboratories_Q2_Results_FY27\"><\/span><strong>What was the net profit margin in Divi&#8217;s Laboratories Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The net profit margin was 31.3% in Divi&#8217;s Laboratories Q2 Results FY27, compared with 25.4% in the comparison quarter, which means profit grew faster than revenue, as the Performance Analysis section explains.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_the_return_on_equity_around_Divis_Laboratories_Q2_Results_FY27\"><\/span><strong>What was the return on equity around Divi&#8217;s Laboratories Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Return on equity was 16.19% in FY26, the latest full-year figure supplied alongside Divi&#8217;s Laboratories Q2 Results FY27 and discussed in the Key Business Factors section of this article.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_business_factors_shaped_Divis_Laboratories_Q2_Results_FY27\"><\/span><strong>What business factors shaped Divi&#8217;s Laboratories Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue growth of 34.3%, net profit growth of 65.5% and a margin of 31.3% were the three business factors listed for Divi&#8217;s Laboratories Q2 Results FY27, as the Key Business Factors section details.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_risks_after_Divis_Laboratories_Q2_Results_FY27\"><\/span><strong>What are the key risks after Divi&#8217;s Laboratories Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Key Risks section notes that one quarter does not set a trend and that return on equity is an annual figure rather than a quarterly one, so later filings carry the next comparison.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_outlook_after_Divis_Laboratories_Q2_Results\"><\/span><strong>What is the outlook after Divi&#8217;s Laboratories Q2 Results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> FY27 full-year results will depend on subsequent quarters and disclosed sector conditions, so Divi&#8217;s Laboratories Q2 Results are one data point, and the FY27 Outlook section describes how later filings add comparisons.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Where_can_I_find_the_complete_Divis_Laboratories_Q2_Results_FY27_data\"><\/span><strong>Where can I find the complete Divi&#8217;s Laboratories Q2 Results FY27 data?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The complete Divi&#8217;s Laboratories Q2 Results FY27 figures sit in the Financial Highlights table above, while the Univest Screener lets you follow later filings and compare net profit trends in one place.<\/p>\n<p><script type=\"application\/ld+json\" class=\"faq-schema\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What are Divi's Laboratories Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Divi's Laboratories Q2 Results FY27 are the quarterly results for July to September 2026, showing revenue of Rs 3,647 Cr. Alongside this, net profit came in at Rs 1,140 Cr, as set out in the Quick Answer.\"}},{\"@type\":\"Question\",\"name\":\"What is the results date for Divi's Laboratories Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Divi's Laboratories declared its Q2 FY27 results on 7 November 2026, which is the results date for the July to September quarter. This date is also stated in the opening paragraph of this article.\"}},{\"@type\":\"Question\",\"name\":\"What revenue was reported in Divi's Laboratories Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Divi's Laboratories reported revenue of Rs 3,647 Cr for Q2 FY27, compared with Rs 2,715 Cr a year earlier, as shown in the Financial Highlights table that follows the introduction.\"}},{\"@type\":\"Question\",\"name\":\"What net profit was reported in Divi's Laboratories Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Divi's Laboratories reported net profit of Rs 1,140 Cr in Q2 FY27, compared with Rs 689 Cr in the same quarter last year, as the Key Takeaways section lists it with its 65.46% rise.\"}},{\"@type\":\"Question\",\"name\":\"How much YoY growth did revenue show in Divi's Laboratories Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue showed YoY growth of 34.33% in Divi's Laboratories Q2 Results FY27, moving from Rs 2,715 Cr to Rs 3,647 Cr, which the Performance Analysis section describes as a difference of Rs 932 Cr.\"}},{\"@type\":\"Question\",\"name\":\"Did net profit rise or fall in Divi's Laboratories Q2 Results?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Net profit rose in Divi's Laboratories Q2 Results, by 65.46% YoY to Rs 1,140 Cr, while the net profit margin moved to 31.3% from 25.4%, a point covered in the Key Business Factors section.\"}},{\"@type\":\"Question\",\"name\":\"What was the net profit margin in Divi's Laboratories Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The net profit margin was 31.3% in Divi's Laboratories Q2 Results FY27, compared with 25.4% in the comparison quarter, which means profit grew faster than revenue, as the Performance Analysis section explains.\"}},{\"@type\":\"Question\",\"name\":\"What was the return on equity around Divi's Laboratories Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Return on equity was 16.19% in FY26, the latest full-year figure supplied alongside Divi's Laboratories Q2 Results FY27 and discussed in the Key Business Factors section of this article.\"}},{\"@type\":\"Question\",\"name\":\"What business factors shaped Divi's Laboratories Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue growth of 34.3%, net profit growth of 65.5% and a margin of 31.3% were the three business factors listed for Divi's Laboratories Q2 Results FY27, as the Key Business Factors section details.\"}},{\"@type\":\"Question\",\"name\":\"What are the key risks after Divi's Laboratories Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The Key Risks section notes that one quarter does not set a trend and that return on equity is an annual figure rather than a quarterly one, so later filings carry the next comparison.\"}},{\"@type\":\"Question\",\"name\":\"What is the outlook after Divi's Laboratories Q2 Results?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"FY27 full-year results will depend on subsequent quarters and disclosed sector conditions, so Divi's Laboratories Q2 Results are one data point, and the FY27 Outlook section describes how later filings add comparisons.\"}},{\"@type\":\"Question\",\"name\":\"Where can I find the complete Divi's Laboratories Q2 Results FY27 data?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The complete Divi's Laboratories Q2 Results FY27 figures sit in the Financial Highlights table above, while the Univest Screener lets you follow later filings and compare net profit trends in one place.\"}}]}<\/script><br \/>\n<script type=\"application\/ld+json\" class=\"news-article-schema\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"NewsArticle\",\"headline\":\"Divi's Laboratories Q2 Results FY27: PAT Rises 65.46% to Rs 1,140 Cr, Revenue Rs 3,647 Cr\",\"description\":\"Divi's Laboratories Q2 Results: revenue \u20b93,647 Cr and PAT \u20b91,140 Cr. Check YoY growth and quarterly results from the 7 November 2026 filing.\",\"author\":{\"@type\":\"Organization\",\"name\":\"Univest\"},\"publisher\":{\"@type\":\"Organization\",\"name\":\"Univest\",\"url\":\"https:\/\/univest.in\"},\"about\":{\"@type\":\"Corporation\",\"name\":\"Divi's Laboratories Ltd\"}}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Divi&#8217;s Laboratories Q2 Results FY27: revenue Rs 3,647 Cr, up 34.33% YoY, and net profit Rs 1,140 Cr, up 65.46% YoY.<\/p>\n","protected":false},"author":29,"featured_media":342474,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5331],"tags":[],"class_list":["post-342475","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-https-univest-in-blogs-category-results"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["342474"],"rank_math_title":["Divi's Laboratories Q2 Results FY27: PAT Up 65.46% to Rs 1,140 Cr"],"rank_math_description":["Divi's Laboratories Q2 Results: revenue \u20b93,647 Cr and PAT \u20b91,140 Cr. Check YoY growth and quarterly results from the 7 November 2026 filing."],"rank_math_focus_keyword":["Divi's Laboratories Q2 Results"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/divi-s-laboratories-q2-results-fy27-pat-rises-65-46-to-rs-1-140-cr-revenue-rs-3.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/342475","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=342475"}],"version-history":[{"count":0,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/342475\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/342474"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=342475"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=342475"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=342475"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}